They wont have 5 drugs in Phase II once patents are granted.
They should just focus on 1 and not scatter themselves again - they've had Phase II drugs for years and have not been able to carry themselves.
Still need further funds for the 1 DMD trial to see completion of Phase IIb.
Don't get to dream boaty lol
ANPs Pipeline Focus with ATL1102 (CD49d), page-18
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35714 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 37037 | 1 |
View Market Depth
| Last trade - 11.32am 17/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable